Brazil Stroked Covaxin

  • 25-Jul-2021
  • 0 Comments


The Brazilian government has suspended Covaxin's order temporarily.

Following termination of the company's agreement with its partner there, the South American Country's health regulator has suspended the Clinical studies of Bharat Biotech's COVID-19 vaccine, Covaxin.  

Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market.

The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.

 

Precisa Medicamentos was Bharat Biotechs partner in Brazil, providing assistance, guidance and support with regulatory submissions, licensure, distribution, insurance and conduct of phase III clinical trials, among others.

Related

News